ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Approval of PBT2 Orphan Designation for Huntingtons Disease, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,498 Posts.
    lightbulb Created with Sketch. 94
    Well just imagine what the viewing will be like in the next few weeks - this news was never meant to be a big kicker- especially given it was already out on ema website last week. Imagine imagine imagine what those extension results might reveal.. Or the release of the partial hold or accelerated approval ... Forget the popcorn .. Im getting some johnny blue label and taking a day off work the next day
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.